{"url_path":"/sec/krmd/8-k/2026-06-30/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/704440/0001161697-26-000139-index.html","accession_number":"0001161697-26-000139","cik":"0000704440","ticker":"KRMD","issuer_name":"KORU Medical Systems, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/704440/0001161697-26-000139-index.html","primary_entity_key":"0000704440","primary_entity_name":"KORU Medical Systems, Inc."},"word_count":318,"has_tables":true,"body_markdown":"Form 8-K\n\nfalse\n0000704440\n\n0000704440\n\n2026-06-24\n2026-06-24\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, DC 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or 15(d) of the Securities\nExchange Act of 1934**\n\n \n\nDate of Report (Date of earliest event reported)   **June 24, 2026**\n\n \n\n**KORU Medical Systems, Inc.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Delaware**\n**0-12305**\n**13-3044880**\n\n(State or other jurisdiction\n\nof incorporation)\n(Commission\n\nFile Number)\n(IRS Employer\n\nIdentification No.)\n\n \n\n**100 Corporate Drive, Mahwah, NJ**\n**07430**\n\n(Address of principal executive offices)\n(Zip Code)\n\n \n\nRegistrant’s telephone number, including area\ncode   **(845) 469-2042**\n\n \n\n______________________________________________\n\n(Former name or former address, if changed since last report)\n\n \n\nCheck the appropriate box below if the Form 8-K filing\nis intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction\nA.2. below):\n\n \n\n[_]  Written communications pursuant to\nRule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n[_]  Soliciting material pursuant to Rule\n14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n[_]  Pre-commencement communications pursuant\nto Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n[_]  Pre-commencement communications pursuant\nto Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b) of\nthe Act:\n\n \n\nTitle of each class\nTrading symbol(s)\nName of each exchange on which registered\n\n**common stock, $0.01 par value**\n**KRMD**\n**The Nasdaq Stock Market**\n\n \n\nIndicate by check mark whether the registrant is an\nemerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company  [_]\n\n \n\nIf an emerging growth company, indicate by check mark\nif the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards\nprovided pursuant to Section 13(a) of the Exchange Act.  [_]"}